🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

445 results for “SK” Clear

  1. Shexiang Baoxin pill（MUSKARDIA）

    Disc Medicine

    Ischemia With Non-Obstructive Coronary Artery

    approved other completed

    1 trial

  2. Skin stretching device (SSD)

    The First People's Hospital of Lianyungang

    Trauma

    approved other active

    1 trial

  3. Sorvasta 20 mg filmsko obložene tablete, Sorvitimb 20 mg/10 mg filmsko obložene tablete, Sorvasta 10 mg filmsko obložene tablete, Sorvasta 40 mg filmsko obložene tablete, Sorvitimb 40 mg/10 mg filmsko obložene tablete

    Novo Nordisk A/S

    Hyperlipidaemia

    approved small molecule active

    1 trial

  4. Subutex 300 mg injektionsvätska, depotlösning, Subutex 100 mg injektionsvätska, depotlösning

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule active

    1 trial

  5. Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete

    Novo Nordisk A/S

    Arterial hypertension

    approved small molecule active

    1 trial

  6. Tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Skin Diseases, Bacterial

    approved small molecule completed

    1 trial

  7. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia (TD)

    approved small molecule completed

    2 trials

  8. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    approved small molecule terminated

    1 trial

  9. biphasic insulin aspart 30

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  10. insulin detemir

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  11. risperidone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Neuroleptic-Induced Tardive Dyskinesia

    approved small molecule completed

    1 trial

  12. turoctocog alfa

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    approved small molecule completed

    2 trials

  13. Amway Herbal Drink

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Skin Laxity

    other active

    1 trial

  14. Astaxanthin (2mg)+Lycopene (1.8mg)+D-Alpha-Tocopherol (10IU)

    United Therapeutics Europe Ltd

    Skin Aging

    other completed

    1 trial

  15. Control (Standard treatment)

    Grace Therapeutics

    Moisture Associated Skin Damage

    small molecule active

    1 trial

  16. Dexmedetomidine-Esketamine Combination

    The First People's Hospital of Lianyungang

    Aged

    small molecule active

    1 trial

  17. Dexmedetomidine-esketamine combination

    The First People's Hospital of Lianyungang

    Liver Cancer

    small molecule completed

    1 trial

  18. Erythromycin 4% topical gel formulation:

    BRIGHT MINDS BIOSCIENCES INC.

    Inflammation; Skin

    small molecule completed

    1 trial

  19. Esketamine

    The First People's Hospital of Lianyungang

    Post Induction Hypotension

    small molecule active

    1 trial

  20. Esketamine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Anesthesia

    small molecule active

    1 trial

  21. Esketamine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    small molecule completed

    1 trial

  22. Esketamine at low dose

    The First People's Hospital of Lianyungang

    Insomnia

    small molecule active

    1 trial

  23. Esketamine nasal spray

    United Therapeutics Europe Ltd

    Depression

    small molecule completed

    1 trial

  24. Esketamine, Sulfentanil or/and Remifentanil

    Second Affiliated Hospital of Soochow University

    Opioid Analgesic Adverse Reaction

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources